Key Takeaways
- • Yellow Wood Partners is acquiring seven Nestle supplement brands—Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride, and Sisu—plus the US private-label supplements business for $1 billion, targeting a portfolio that generated approximately $1.2 billion in sales during 2025.
- • The transaction aligns with CEO Philipp Navratil's strategic portfolio rationalization effort, which has already reduced Nestle's exposure to ice cream and bottled water through disposals and joint ventures since his appointment one year ago.
- • Nestle will retain Solgar, its premium vitamins and supplements brand, signaling a deliberate pivot toward higher-margin, differentiated product categories and away from mainstream supplement commoditization.
- • The deal represents Yellow Wood's seventh established consumer brand acquisition since 2019, following the firm's track record of acquiring divested assets from larger corporate owners, including ChapStick from Haleon and Elida Beauty from Unilever.
- • Transaction closure is expected in the first half of 2027, subject to customary regulatory conditions and approvals.
Summary
Private equity firm Yellow Wood Partners has agreed to acquire a portfolio of mainstream vitamins, minerals, and supplements brands from Nestle for $1 billion, according to Reuters. The transaction encompasses seven brands—Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride, and Sisu—alongside Nestle's US private-label supplements operations. The portfolio generated approximately $1.2 billion in sales during 2025, indicating a valuation multiple below trailing revenues.
The divestiture forms part of a broader capital reallocation strategy under CEO Philipp Navratil, who assumed the role one year ago. Navratil has systematically reduced Nestle's exposure to mature, commoditized categories through targeted disposals and joint ventures, including businesses in ice cream and bottled water. The supplements sale reflects management's conviction that the mainstream vitamins and minerals category lacks sufficient competitive differentiation to justify Nestle's continued ownership and capital allocation. Notably, Nestle acquired several divested brands through its $5.75 billion acquisition of The Bountiful Company in 2021, suggesting the company may be recalibrating returns from that prior transaction.
Yellow Wood's acquisition strategy focuses on acquiring established consumer brands separated from larger corporate parents—a market segment that has generated attractive acquisition opportunities. Since 2019, the firm has completed six such transactions, including the acquisition of ChapStick from Haleon and Elida Beauty from Unilever. This transaction represents its seventh investment in this category, reinforcing a repeatable playbook around carve-outs and divestitures.
Strategically, Nestle's decision to retain Solgar, its premium vitamins and supplements brand, underscores management's intent to concentrate resources in higher-margin, differentiated product segments while exiting mainstream supplement categories vulnerable to private-label competition and commoditization pressure. The transaction is expected to close in the first half of 2027, subject to customary regulatory and antitrust approvals.
The divestiture forms part of a broader capital reallocation strategy under CEO Philipp Navratil, who assumed the role one year ago. Navratil has systematically reduced Nestle's exposure to mature, commoditized categories through targeted disposals and joint ventures, including businesses in ice cream and bottled water. The supplements sale reflects management's conviction that the mainstream vitamins and minerals category lacks sufficient competitive differentiation to justify Nestle's continued ownership and capital allocation. Notably, Nestle acquired several divested brands through its $5.75 billion acquisition of The Bountiful Company in 2021, suggesting the company may be recalibrating returns from that prior transaction.
Yellow Wood's acquisition strategy focuses on acquiring established consumer brands separated from larger corporate parents—a market segment that has generated attractive acquisition opportunities. Since 2019, the firm has completed six such transactions, including the acquisition of ChapStick from Haleon and Elida Beauty from Unilever. This transaction represents its seventh investment in this category, reinforcing a repeatable playbook around carve-outs and divestitures.
Strategically, Nestle's decision to retain Solgar, its premium vitamins and supplements brand, underscores management's intent to concentrate resources in higher-margin, differentiated product segments while exiting mainstream supplement categories vulnerable to private-label competition and commoditization pressure. The transaction is expected to close in the first half of 2027, subject to customary regulatory and antitrust approvals.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.